In Vivo Base Editing Gene Therapy for Heterozygous Familial Hypercholesterolemia with GalNAc-modified Lipid Nanoparticles
In Vivo Base Editing Gene Therapy for Heterozygous Familial Hypercholesterolemia with GalNAc-modified Lipid Nanoparticlesoriginal data